Posted on 15 December 2025
GLP-1 injections, the most famous of which you might recognise (the drug Ozempic ring a bell?), have taken the medical world by storm over the past few years. A bidding war between major players over acquiring one of these anti-obesity drugs, made for an eventful couple of weeks. In this article, we'll explore the circumstances surrounding the bidding war that culminated in Pfizer's acquisition of Metsera, as well as the implications of the acquisition itself.